Dr. Jorge G. Gomez-Gutierrez earned his B.S. in 2001
and his Ph.D. in 2006 from the University of Nuevo León. He is currently an
Associate Professor of Pediatrics and a NextGen Precision Health Investigator.
Dr. Gomez-Gutierrez's research focuses on microbial-based cancer therapies,
particularly using virus- and bacteria-based treatments to inhibit tumor growth
and induce oncolysis or immune responses where conventional therapies are
insufficient. His lab studies conditionally replicating adenoviruses (oncolytic
adenoviruses) and the lactic acid bacterium Lactococcus lactis, commonly used
in the dairy industry.
Dr. Jorge G. Gomez-Gutierrez earned his B.S. in 2001
and his Ph.D. in 2006 from the University of Nuevo León. He is currently an
Associate Professor of Pediatrics and a NextGen Precision Health Investigator.
Dr. Gomez-Gutierrez's research focuses on microbial-based cancer therapies,
particularly using virus- and bacteria-based treatments to inhibit tumor growth
and induce oncolysis or immune responses where conventional therapies are
insufficient. His lab studies conditionally replicating adenoviruses (oncolytic
adenoviruses) and the lactic acid bacterium Lactococcus lactis, commonly used
in the dairy industry.